Waters Past Earnings Performance
Past criteria checks 2/6
Waters has been growing earnings at an average annual rate of 4.9%, while the Life Sciences industry saw earnings growing at 19.1% annually. Revenues have been growing at an average rate of 6.1% per year. Waters's return on equity is 55.8%, and it has net margins of 21.7%.
Key information
4.9%
Earnings growth rate
9.3%
EPS growth rate
Life Sciences Industry Growth | 26.8% |
Revenue growth rate | 6.1% |
Return on equity | 55.8% |
Net Margin | 21.7% |
Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Waters makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 2,956 | 642 | 697 | 175 |
30 Sep 23 | 2,995 | 653 | 729 | 179 |
01 Jul 23 | 2,992 | 675 | 696 | 180 |
01 Apr 23 | 2,966 | 689 | 682 | 178 |
31 Dec 22 | 2,972 | 708 | 658 | 176 |
01 Oct 22 | 2,950 | 697 | 658 | 171 |
02 Jul 22 | 2,901 | 702 | 645 | 170 |
02 Apr 22 | 2,868 | 705 | 641 | 171 |
31 Dec 21 | 2,786 | 693 | 627 | 168 |
02 Oct 21 | 2,736 | 695 | 606 | 165 |
03 Jul 21 | 2,671 | 660 | 563 | 158 |
03 Apr 21 | 2,509 | 616 | 541 | 144 |
31 Dec 20 | 2,365 | 522 | 555 | 141 |
26 Sep 20 | 2,295 | 504 | 507 | 138 |
27 Jun 20 | 2,278 | 515 | 524 | 138 |
28 Mar 20 | 2,358 | 537 | 522 | 143 |
31 Dec 19 | 2,407 | 592 | 526 | 143 |
28 Sep 19 | 2,405 | 577 | 582 | 144 |
29 Jun 19 | 2,406 | 580 | 584 | 145 |
30 Mar 19 | 2,403 | 591 | 589 | 144 |
31 Dec 18 | 2,420 | 594 | 585 | 143 |
29 Sep 18 | 2,392 | 55 | 543 | 140 |
30 Jun 18 | 2,380 | 51 | 550 | 139 |
31 Mar 18 | 2,342 | 27 | 540 | 136 |
31 Dec 17 | 2,309 | 20 | 545 | 133 |
30 Sep 17 | 2,251 | 548 | 512 | 130 |
01 Jul 17 | 2,212 | 537 | 501 | 127 |
01 Apr 17 | 2,190 | 533 | 502 | 127 |
31 Dec 16 | 2,167 | 522 | 512 | 125 |
01 Oct 16 | 2,125 | 498 | 508 | 121 |
02 Jul 16 | 2,099 | 490 | 509 | 121 |
02 Apr 16 | 2,057 | 467 | 502 | 119 |
31 Dec 15 | 2,042 | 469 | 493 | 119 |
03 Oct 15 | 2,040 | 469 | 498 | 119 |
04 Jul 15 | 2,032 | 467 | 496 | 116 |
04 Apr 15 | 2,019 | 457 | 501 | 112 |
31 Dec 14 | 1,989 | 432 | 502 | 108 |
27 Sep 14 | 1,971 | 422 | 501 | 106 |
28 Jun 14 | 1,935 | 406 | 500 | 102 |
29 Mar 14 | 1,904 | 399 | 495 | 100 |
31 Dec 13 | 1,904 | 450 | 493 | 101 |
28 Sep 13 | 1,861 | 484 | 484 | 99 |
29 Jun 13 | 1,853 | 485 | 479 | 99 |
Quality Earnings: WAZ has high quality earnings.
Growing Profit Margin: WAZ's current net profit margins (21.7%) are lower than last year (23.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WAZ's earnings have grown by 4.9% per year over the past 5 years.
Accelerating Growth: WAZ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: WAZ had negative earnings growth (-9.3%) over the past year, making it difficult to compare to the Life Sciences industry average (6.5%).
Return on Equity
High ROE: Whilst WAZ's Return on Equity (55.83%) is outstanding, this metric is skewed due to their high level of debt.